---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-26-002682"
form_type: "8-K"
ticker: "NRXP"
cik: "0001719406"
company_name: "NRX Pharmaceuticals, Inc."
filed_at: "2026-02-02T23:59:59+00:00"
generated_at: "2026-05-16T05:39:25.678551+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# NRx Pharmaceuticals appoints Joseph M. Casper as COO; base salary $250,000 plus options

## Summary
- Joseph M. Casper appointed Chief Operating Officer effective January 27, 2026.
- Casper has 35 years of healthcare experience including Deloitte, Kaiser Permanente, and Anthem.
- Annual base salary of $250,000 with a bonus of 25% subject to milestones with CEO.
- Granted 100,000 options: 33.3% vest June 1, 2026, 33.3% Dec 1, 2026, 33.3% Dec 1, 2027.

## SEC filing metadata
- accession: 0001437749-26-002682
- form_type: 8-K
- ticker: NRXP
- cik: 0001719406
- company_name: NRX Pharmaceuticals, Inc.
- filed_at: 2026-02-02T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1719406/000143774926002682/0001437749-26-002682-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1719406/000143774926002682/nrxp20260202_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-26-002682
- JSON: https://secwatch.observer/filing/0001437749-26-002682.json
- Plain text: https://secwatch.observer/filing/0001437749-26-002682.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.